期刊文献+

跨膜蛋白MS4A8B在前列腺癌组织中的表达及意义 被引量:2

The expression and clinical significance of MS4A8B in prostate cancer tissue
原文传递
导出
摘要 目的:探讨跨膜蛋白MS4A8B在前列腺癌组织中的表达及意义。方法:采用免疫组织化学检测140例临床局限性前列腺癌行前列腺癌根治术样本的组织微阵列芯片上的MS4A8B,并将MS4A8B与增殖指数(PCNA)和凋亡指数(TUNEL)进行相关性分析,将患者的年龄、PSA水平、Gleason评分及生化复发等临床病理特征与MS4A8B进行统计学处理。结果:良性组织、癌旁组织、前列腺上皮内瘤变、前列腺原发癌和前列腺转移淋巴结的MS4A8B蛋白表达分别为0%、1.94%、5.92%、62.6%和70.4%。Kaplan-Meier生存曲线分析表明前列腺癌组织高表达患者较低表达患者无生化复发生存时间(RFS)明显缩短(P<0.05);进一步研究发现MS4A8B蛋白表达与患者Gleason评分、增殖指数呈正相关(Spearman分析)(P<0.001)。结论:MS4A8B的表达与前列腺癌根治术后生化复发和转移相关,并在前列腺癌进展中扮演重要角色。 Objective:To clarify the expression and clinical significance of MS4A8B in prostate cancer. Meth- ods:In 140 clinically localized prostate cancer tissue samples undergoing radical prostatectomy, immunohistochemi- cal staining was performed. Statistical analysis was used to determine the correlation between MS4A8B and PCNA protein level as an index of proliferative activity, TUNEL staining as an index of apoptosis. We further analyzed statistically the value of the MS4A8B expression evaluating clinicopathological characteristics such as age, PSA at diagnosis, Gleason score, and biochemical recurrence. Results:Positive ratios of MS4A8B protein expression were 0%, 1. 940/00, 5.92%, 62.6% and 70.4% in benign, benign adjacent to prostate cancer, HPIN, primary and me- tastatic prostate cancer, respectively. Kaplan-Meier curves revealed that the recurrence--free survival (RFS) of the patients with high MS4A8B expression were shorter than that with low MS4A8B expression. Moreover, MS4A8B was positively associated with Gleason score, the proliferation index (all p~ 0. 001). Conclusions: MS4A8B expression is associated with early biochemical relapse and metastasis after radical prostatectomy which plays an important role in progression of human prostate cancer
出处 《临床泌尿外科杂志》 2013年第8期599-603,606,共6页 Journal of Clinical Urology
基金 中国博士后科学基金资助项目(编号2013M531123) 上海市博士后科研资助计划面上项目(编号12R21411600) 国家自然科学基金资助项目(编号30973009)
关键词 前列腺癌 MS4A8B蛋白 生化复发 prostate cancer MS4A8B biochemical recurrence
  • 相关文献

参考文献19

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012[J]. CA Cancer J Clin, 2012, 62(1) :10-29.
  • 2Liang Y, Tedder T F. Identification of a CD20-, Fcepsi-lonRIbeta-, and HTm4-related gene family: sixteen new MS4A family members expressed in human and mouse [J]. Genomics, 2001, 72(2) .. 119- 127.
  • 3Kutok J L, Yang X, Folkerth R, et al. Characterization of the expression of HTm4 (MS4A3), a cell cycle regulator, in human peripheral blood cells and normal and malignant tissues[J]. J Cell Mol Med, 2011, 15(1):86.
  • 4Michel J, Schonhaar K, Schledzewski K, et al. Identifi- cation of the novel differentiation marker MS4A8B and its routine homolog MS4ASA in colonic epithelial cells lost during neoplastic transformation in human eolon[J]. Cell Death Dis, 2013, 4:e469.
  • 5Chen H, Li C, Fang M, et al. Understanding Hae- mophilus parasuis infection in porcine spleen through a transcriptomics approach [J]. BMC Genomics, 2009,10:64.
  • 6Lonergan K M, Chari R, Deleeuw R J, et al. Identifica- tion of novel lung genes in bronchial epithelium by serial analysis of gene expression[J]. Am J Respir Cell Mol Biol, 2006, 35(6) :651-661.
  • 7Schmieder A, Schledzewski K, Michel J, et al. The CD20 homolog Ms4a8a integrates pro-and anti-inflamma- tory signals in novel M2-like macrophages and is ex- pressed in parasite infection[J]. Eur J Immunol, 2012, 42(11) :2971-2982.
  • 8Schmieder A, Schledzewski K, Michel J, et al. Syner- gistic activation by p38MAPK and glucocorticoid signa- ling mediates induction of M2-like tumor-associated mac- rophages expressing the novel CD20 homolog MS4ASA [J]. Int J Cancer, 2011, 129(1):122-132.
  • 9Ghani M, Pinto D, Lee J H, et al. Genome-wide survey of large rare copy number variants in Alzheimer's disease among Caribbean hispanics[J]. G3 (Bethesda), 2012, 2 (1) ,71-78.
  • 10Kamboh M I, Demirci F Y, Wang X, et al. Genome- wide association study of Alzheimer's disease[J]. Transl Psychiatry, 2012, 2:e117.

同被引文献71

  • 1杨铭,范冬梅,熊冬生,刘银星,许元富,杨纯正.抗CD20嵌合抗体片段Fab′突变体对B淋巴细胞凋亡及胞内Ca^(2+)的影响[J].肿瘤,2006,26(2):116-119. 被引量:1
  • 2Liang Y, Buckley TR, Tu L, et al. Structural organization of the human MS4A gene cluster on chromosome 11q12[J]. Immunogenetics, 2001, 53(5):357-368.
  • 3Zuccolo J, Bau J, Childs S J, et al. Phylogenetic analysis of the MS4A and TMEM176 gene families[J]. PLoS One, 2010, 5(2):e9369.
  • 4Thomas DA, O'Brien S, Kantarjian HM. Monoclonal antibody therapy withrituximab for acute lymphoblastic leukemia[J]. Hematol Oncol Clin North Am, 2009, 23(5):949-971.
  • 5Cruse G, Beaven MA, Ashmole I, et al. A truncated splice-variant of the Fc:RI: receptor subunit is critical for microtubule formation and degranulation in mast cells[J], Immunity, 2013, 38(5):906-917.
  • 6Heller G, Rommer A, Steinleitner K, et al. EVll promotes tumor growth viatranscriptional repression of MS4A3[J]. J Hematol Oncol, 2015(8):28.
  • 7Donato J L, Ko J, Kutok JL, et al. Human HTm4 is a hematopoietic cell cycle regulator[J].J Clin Invest, 2002, 109(1 ):51-58.
  • 8Ye L, Yao XD, Wan FN, et al. MS4ASB promotes cell proliferation in prostate cancer[J]. Prostate, 201 4, 74(9):911-922.
  • 9Koslowski M. Sahin U, Dhaene K,et al. MS4A12 is a colon-selective store-operated calcium channel promoting malignant cell processes[j]. Cancer Res, 2008, 68(9):3458-3466.
  • 10Liang Y, Tedder TF. Identification of a CD20-, FcepsilonRIbeta-, and HTm4- related gene family: sixteen new MS4A family members expressed in human and mouse[J]. Cenomics, 2001, 72(2):119-127.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部